研究実績

Phase I/II study of weekly taxol plus irinotecan for patients with advanced of recurrent gastric cancer (OGSG0104)

M. Imano, Y-F.Peng, H. Imamoto, H.Shiozaki, K K.Kobayashi, T. Aoki, H.Furukawa, T.Tsujinaka, F. Uedo, H. Imamura, S. Iijima, T. Shimokawa, T. Taguchi(2008). Phase I/II study of weekly taxol plus irinotecan for patients with advanced of recurrent gastric cancer (OGSG0104). 7th International Gastric Cancer Congress.

前の記事 次の記事 一覧ページへ戻る